- Filed
- Nov 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 7, 2025 | 11.86M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 7.42M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 6.82M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 5.97M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 5.92M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $9.78M |
| Capex | Q3 2025 · Sep 30, 2024 | $21.5M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$20.78M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$12.02M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $106.66M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $183.24M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$22.05M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$82.41M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$74.94M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$67.32M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $45.91M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $66.61M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $19.18M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $48.14M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $122.22M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $139.94M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $512.84M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $675.09M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $143.72M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $231.22M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $511.45M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $607.78M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −2.76 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −7.16 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.76 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$7.16 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −4.74 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −3.74 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$4.74 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$3.74 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | 0.98 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −3.27 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.98 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$3.27 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −4.74 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −3.74 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$4.74 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$3.74 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $10.97M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $35.7M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $17.66M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $63.67M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $13.38M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $43.25M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $18.18M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $62.49M |
| Net Income | Q3 2025 · Sep 30, 2025 | $8.71M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$21.13M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$15.71M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$14.13M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$28.31M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$22.15M |
| Net Income | Q3 2025 · Jun 30, 2024 | $41.8M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$35.63M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$14.59M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$37.96M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$16.04M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$82.2M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $17.22M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $53.47M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $19.98M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $60.87M |
| Revenue | Q3 2025 · Sep 30, 2025 | $60.15M |
| Revenue | Q3 2025 · Sep 30, 2025 | $184.45M |
| Revenue | Q3 2025 · Sep 30, 2024 | $74.24M |
| Revenue | Q3 2025 · Sep 30, 2024 | $239.27M |